Dammarane-Type Triterpenoids from the Roots of and Their Preventive Effects on Zebrafish Heart Failure and Thrombosis.

J Nat Prod

State Key Laboratory of Drug Research , Shanghai Institute of Materia Medica, Chinese Academy of Sciences , 555 Zu Chong Zhi Road , Zhangjiang Hi-Tech Park, Shanghai 201203 , People's Republic of China.

Published: February 2020

Eight new dammarane-type triterpenoids (-), together with a related known analogue (), were isolated from the roots of , a traditional Chinese medicine for treating coronary artery heart disease, guided by LC-MS analysis. Their structures were elucidated based on extensive spectroscopic analysis and quantum chemical calculations. Notably, compounds - and possess an unusual 17side chain, and -, , and contain an uncommon 3-methyl-5,6-dihydro-2-pyran-2-one moiety in the side chain. Compounds - and have a 3,19-hemiketal bridge in the A ring. In an in vivo bioassay, , , and - exhibited significant preventive effects on zebrafish heart failure at 0.5 g/mL, improving heart dilatation, venous congestion, cardiac output, blood flow velocity, and heart rate. Compound , displaying the most promising heart failure preventive activities, showed even better effects on increasing cardiac output (72%) and blood flow velocity (83%) than six first-line heart failure therapeutic drugs. Moreover, , , and prevented the formation of thrombosis in zebrafish at 0.5 g/mL. The present investigation suggests that the new dammarane triterpenoids might be partially responsible for the utility of in treating coronary artery heart disease.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jnatprod.9b00857DOI Listing

Publication Analysis

Top Keywords

heart failure
16
dammarane-type triterpenoids
8
preventive effects
8
effects zebrafish
8
heart
8
zebrafish heart
8
treating coronary
8
coronary artery
8
artery heart
8
heart disease
8

Similar Publications

Background: Autosomal recessive cutis laxa type 1B (ARCL1B) is an extremely rare disease characterized by severe systemic connective tissue abnormalities, including cutis laxa, aneurysm and fragility of blood vessels, birth fractures and emphysema. The severity of this disease ranges from perinatal death to manifestations compatible with survival. To date, no cases have been reported in the Chinese population.

View Article and Find Full Text PDF

Introduction: Clinicians are the conduits of high-quality care delivery. Clinicians have driven advancements in pharmacotherapeutics, devices, and related interventions and improved morbidity and mortality in patients with congestive heart failure over the past decade. Yet, the management of congestive heart failure has become extraordinarily complex and has fueled recommendations from the American Heart Association and the American College of Cardiology to optimize the composition of the care team to reduce the health, economic, and the health system burden of high lengths of stay and hospital charges.

View Article and Find Full Text PDF

An 88-year-old male with a history of cervical spondylosis (status post laminectomy of C2-C3 and laminoplasty of C4-C5), chronic congestive heart failure (CHF), pulmonary embolism, and lumbar spinal stenosis presented to an outpatient sports medicine clinic with neck pain following a fall five days prior due to loss of balance. He reported pain on the left side worsened by movement and accompanied by neck "clicking." A physical exam showed severe limitation in cervical spine extension limited by pain and loss of lordotic curve and a neurologic exam demonstrated weakness in the left leg secondary to a previous back surgery.

View Article and Find Full Text PDF

Endovascular treatment of postoperative aortic coarctation aneurysms-a single center experience.

Front Cardiovasc Med

December 2024

Department of Cardiology, University Hospital 'St. Ekaterina', Medical University of Sofia, Sofia, Bulgaria.

Background: Formation of local type aortic aneurysm years after surgical repair of coarctation (CoA) occurs in 10% of patients independent of the surgical technique and is a potentially life-threatening condition if left untreated with a high risk of aortic rupture. Redo open surgery is associated with 14% in-hospital mortality and a high risk of complications. Endovascular treatment appears to be a feasible alternative with a high success rate and low morbidity and mortality, but data concerning long-term results is still mandatory.

View Article and Find Full Text PDF

Left ventricular assist devices (LVADs) have been used as a bridge to transplantation in patients with advanced heart failure. In this case, LVAD therapy was used as a destination therapy for 16 years, representing the longest documented and continuously ongoing support with the original implanted device.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!